Live feed21:30:07·142dINSIDERFilingvia QuantisnowSVP, CHIEF ACCOUNTING OFFICER Calvin Sandra was granted 15,180 shares and sold $139,176 worth of shares (4,333 units at $32.12), increasing direct ownership by 28% to 49,080 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.TVTX· Travere Therapeutics Inc.Health CareOriginal source